Transaction Details

Footnotes

The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 22, 2024. | Includes 19.0004 shares acquired under a dividend reinvestment plan. | This transaction was executed in multiple trades at prices ranging from $349.01 to $350.00. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | This transaction was executed in multiple trades at prices ranging from $350.39 to $351.31. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | This transaction was executed in multiple trades at prices ranging from $351.45 to $352.42. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | This transaction was executed in multiple trades at prices ranging from $352.45 to $353.43. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | This transaction was executed in multiple trades at prices ranging from $353.45 to $353.99. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. | Option fully vested. | Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 22, 2024. | Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column. | 1 for 1. | The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment. | If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. | If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. | If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.